RT Journal Article
SR Electronic
A1 Parry, Nicola
T1 Darapladib Ineffective at Reducing Major Coronary Events after ACS
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 27
SP 17
OP 17
DO 10.1177/155989771427010
UL http://mdc.sagepub.com/content/14/27/17.1.abstract
AB This article presents primary results from The Stabilization of Plaques Using Darapladib-TIMI 52 trial [SOLID-TIMI 52; NCT01000727], demonstrating that darapladib is ineffective at reducing major coronary events when started within 30 days after an acute coronary syndrome (ACS) event.